The Shotlee Journal
Expert insights on GLP-1 medications, peptide therapy, and evidence-based approaches to weight management.
Loading articles...
Showing 9 / 1308 articles
Bariatric surgery significantly impacts glucose and insulin responses. This post explores the nuances of these changes, focusing on the impact of different surgical procedures, sex-based differences, and the implications for personalized treatment of metabolic conditions.
Whoopi Goldberg's recent weight loss has sparked conversations about her health, including her struggles with sciatica and the pressures of Hollywood. This article explores her journey and the challenges faced by aging women in the entertainment industry.
Katherine Ryan's post-pregnancy plans have shone a spotlight on GLP-1 medications. But what's the real science behind them, and how do they fit into the broader picture of metabolic health and longevity? Let's delve into the details.
The use of GLP-1 medications for weight loss is a hot topic, even among reality TV stars. We break down the debate, explore healthier alternatives, and discuss the importance of holistic health tracking.
New research suggests that GLP-1 agonists, like semaglutide, may reduce alcohol cravings and delay intoxication. The effect is linked to slowed gastric emptying, impacting alcohol absorption. Track your peptide journey and wellness goals using Shotlee.
New research reveals that GLP-1 weight loss injections, such as semaglutide, may offer significant heart health benefits independent of weight loss. This could change how we view and use these medications for long-term health.
Recent approval of Mounjaro (tirzepatide) for obstructive sleep apnea (OSA) in obese individuals signifies a groundbreaking advancement. This development addresses a critical need, offering a novel pharmacological approach to a condition affecting millions.
Obstructive sleep apnea (OSA) affects millions, disrupting sleep and impacting overall health. A recent study explores the effectiveness of hypoglossal nerve stimulation as a promising treatment option for those who haven't found relief with traditional methods.
Tuberculosis remains a global health challenge. Recent research explores the potential of cytochrome bc1 inhibitors in novel treatment regimens, offering a glimpse into future TB therapies. Learn about this promising development.
